Amniotic membrane combined with MMC has similar recurrence rate to CA combined with MMC, in patients with recurrent pterygium. Similar outcomes and complication rates make AMT-MMC a promising method for the treatment of recurrent pterygium cases.
Introduction
The COVID-19 disease emerged in Wuhan province of China in November 2019 and spread across the world in a short time, resulting in a pandemic. The first case in Turkey was detected on March 11, 2020. The aim of the current study was to reveal the effects of COVID-19 on cranial nerves by monitoring people infected with the disease based on repeated examinations and surveys.
Material and method
The data of 356 patients with a positive COVID-19 polymerase chain reaction (PCR) test who received treatment between June 2020 and August 2020 in our hospital were prospectively evaluated after the study was approved by the relevant ethics committee.
Results
Of the 356 patients included in the study, 47 under the age of 18 years were excluded due to their unreliable examination and anamnesis findings. In addition, seven patients that died while in hospital were excluded from the study due to the lack of examination and survey records during their hospitalization. The data of the remaining 302 patients were statistically analyzed. Symptoms of cranial nerve involvement were observed in 135 patients.
Conclusion
The COVID-19 disease caused by the SARS-CoV2 virus commonly results in cranial nerve symptoms. The fact that these findings are more common and severe in COVID-19 than previous SARS and MERS outbreaks suggests that it has a more neurotrophic and more aggressive neuroinvasion. While the negative effects of the virus on sensory functions resulting from cranial nerve involvement are evident, motor functions are rarely affected.
AMT was effective for reconstruction of tissue defect after excision and cryotherapy of limbal and conjunctival tumors. In most of these cases, complete healing was achieved with a smooth, stable, and translucent surface.
Introduction: The COVID-19 disease emerged in Wuhan province
of China in November 2019 and spread across the world in a short time,
resulting in a pandemic. The first case in Turkey was detected on March
11, 2020. The aim of the current study was to reveal the effects of
COVID-19 on cranial nerves by monitoring people infected with the
disease based on repeated examinations and surveys. Material and Method:
The data of 356 patients with a positive COVID-19 polymerase chain
reaction (PCR) test who received treatment between June 2020 and August
2020 in our hospital were prospectively evaluated after the study was
approved by the relevant ethics committee. Results: Of the 356 patients
included in the study, 47 under the age of 18 years were excluded due to
their unreliable examination and anamnesis findings. In addition, seven
patients that died while in hospital were excluded from the study due to
the lack of examination and survey records during their hospitalization.
The data of the remaining 302 patients were statistically analyzed.
Symptoms of cranial nerve involvement were observed in 135 patients.
Conclusion: The COVID-19 disease caused by the SARS-CoV2 virus commonly
results in cranial nerve symptoms. The fact that these findings are more
common and severe in COVID-19 than previous SARS and MERS outbreaks
suggests that it has a more neurotrophic and more aggressive
neuroinvasion. While the negative effects of the virus on sensory
functions resulting from cranial nerve involvement are evident, motor
functions are rarely affected.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.